Skip to main content

Ebola virus Disease Progression

Ebola is a disease caused by the Ebola virus. Ebola virus belongs to the family Filoviridae. Filoviridae is the only virus family about which scientists know very less. Knowledge about the pathogenesis, the diseases caused by this virus family and the detailed virology is still very less. The recent epidemics have provided a considerable amount of understanding about the filoviruses. The first encounter of biomedical science with virus family Filoviridae took place in 1967 when Marburg virus appeared. Similar course of events were presaged by this virus for Ebola virus.

On an average, the incubation period for Ebola Virus disease in humans lasts for 5-9 days though the overall incubation period of Ebola Virus disease in humans ranges from 2 to 21 days. There are three distinct phases in the course of the disease: Generalization phase, early organ phase, late organ phase or convalescence phase depending upon the result of the infection.
  • Generalization phase: This phase begins with symptoms that are largely similar to influenza. High fever, chills, myalgia, malaise, fatigue, loss of appetite, headache, stomachache, nausea, severe diarrhea have all been reported. This phase lasts for about five days after the beginning of the disease. In the middle or later part of the generalization phase, a rash might also be noticed on the face, trunk or other parts which later gets developed as maculopapular rash.
  • Early organ phase: After 5 to 13 days of the onset of the disease, the disease gets progressed into this phase. It is associated with conditions like prostration, dyspnea, exanthema, abnormal vascular permeability, conjunctival injection and edema. This phase marks the beginning of severe phase of the disease. In the later stage of this phase, clear hemorrhagic manifestations can be seen in the patients. Multiple organs like liver, pancreas, and kidneys get affected.
  • Late organ phase: This phase begins after 13 days until more than 20 days after the commencement of the disease. In this phase, the condition of the patient moves to a critical state with multiple organ failure, convulsions, shock etc. Patients may develop neurological symptoms including dementia, restlessness or coma.
  • Convalescence phase: Those who survive the disease may not even enter the late organ phase. During recovery and convalescent phase, complications such as myalgia, arthralgia, asthenia, hepatitis, ocular disease and psychosis may occur.


Popular posts from this blog

Treatment and recovery from ebola

Ebola virus causes Ebola virus disease (EVD), also known as Ebola haemorrhagic fever or Ebola. The disease caused by the virus is often fatal. The virus gets spread by direct contact with bodily fluids or blood of an infected person or infected animal. The symptoms of the disease are not very clear and the disease initially feels like flu. The symptoms include stomach pain, muscle aches, vomit, diarrhea, unexplained bleeding or bruising and fatigue. As of now, there is no known medication or vaccine which is effective. The scientists are still in the early stages of understanding how the infection caused by Ebola virus can be treated. There are a number of experimental treatments that are being considered for use in cases of Ebola outbreaks. The experimental treatments are under clinical trials. As there is no cure for Ebola and research is still going on for finding one, the experimental treatment carried out by the doctors include a serum that is said to destroy the infected cell...
Read more

Ebola virus treatment

 Treating Ebola can feel like navigating a storm in the dark, but it's all about shining a light on the right steps. The approach to handling this deadly virus hinges on supportive care, experimental treatments, and prevention strategies. Let's dive into the essentials. Supportive Care: The Backbone of Treatment First and foremost, supportive care is the backbone of treating Ebola. This involves managing symptoms and complications, keeping patients hydrated, and maintaining their oxygen levels and blood pressure. You’re looking at a regimen of fluids, electrolytes, and medications to counteract nausea, pain, fever, and other symptoms. It's a relentless fight to keep the body's functions in balance while the immune system battles the virus. Experimental Treatments: Hope on the Horizon When it comes to experimental treatments, things get a bit more cutting-edge. Several antiviral drugs and therapies have shown promise in fighting Ebola. For instance, Remdesivir , an antiv...
Read more

Severity of Ebola

The first outbreak of the deadly Ebola disease took place in 1976 first in Sudan, then in Zaire. The disease can be fatal in majority of the cases. It is a viral fever which can get extremely severe in humans and primates. The virus affected around 284 people when it took place for the first time and it took toll over the lives of 53% of its victims. The second time it affected around 318 people and had the highest mortality rate among the viral diseases. The mortality rate was 88% in Zaire. The cause of such deadly disease could not be found as researchers kept trying to find the origin of the virus. In 1989, the third strain of disease, the Ebola Reston (EBOR) was identified for the first time. Monkeys that were imported from Reston were found to be infected with Ebola virus. Till now, Ebola has caused about 4493 deaths and the count of its victims is as high as 8998, according to World Health Organization (WHO). WHO still believes that the numbers can be 2.5 times the numbers that...
Read more